Table 2.
Univariate | Multivariate | ||||||||
---|---|---|---|---|---|---|---|---|---|
Variable | Categories | Odds ratio | 95 % CI | P value | Observations | Odds ratio | 95 % CI | P value | Observations |
Age | Continuous | 0.99 | 0.97, 1.02 | 0.6 | 755 | 0.99 | 0.96-1.02 | 0.44 | 406 |
Tumour size | ≤50 mm, >50 mm | 0.89 | 0.54, 1.48 | 0.66 | 755 | 0.68 | 0.27-1.75 | 0.43 | 406 |
Node status | Negative, positive | 0.8 | 0.54, 1.18 | 0.25 | 755 | 0.56 | 0.31-1.00 | 0.05 | 406 |
Grade | 1, 2, 3 | 3.98 | 2.38, 6.67 | <0.00001 | 588 | 3.62 | 1.74-7.52 | 0.0006 | 406 |
ER status | Negative, positive | 0.26 | 0.17, 0.38 | <0.00001 | 755 | 0.3 | 0.17-0.53 | 0.00004 | 406 |
HER2 status | Negative, positive | 1.6 | 1.03, 2.50 | 0.04 | 665 | 1.81 | 0.97-3.37 | 0.06 | 406 |
Median lymphocyte density | Continuous | 4.46 | 2.34, 8.50 | <0.00001 | 614 | 2.42 | 1.08-5.40 | 0.03 | 406 |
ER oestrogen receptor; HER2 human epidermal growth factor receptor 2